Science Explorer Back to mapMap
Discussion

AZAD Pharma (Switzerland)

Research works
5
fractional, all time
Citations
33
6.9 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
12%
world 40%
International
12%
world 18%

Not ranked overall: AZAD Pharma (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does AZAD Pharma (Switzerland) work in?

In all years, 45% of research at AZAD Pharma (Switzerland) is in Health Sciences, 34% in Physical Sciences. Its largest fields are Medicine (38%), Chemistry (30%), Biochemistry, Genetics and Molecular Biology (21%).

Life Sciences21%Physical Sciences34%Health Sciences45%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Medicine238.3%
    2. Nursing06.4%
    1. Chemistry129.8%
    2. Engineering02.1%
    3. Environmental Science02.1%
    1. Biochemistry, Genetics and Molecular Biology121.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from AZAD Pharma (Switzerland)?

The most cited paper from AZAD Pharma (Switzerland) is "Physicochemical and toxicological characterization of a new generic iron sucrose preparation" (Thomas W. Meier, Patricia Schropp, Christian Pater et al., 2011), with 21 citations. Next come "Biodistribution and predictive hepatic gene expression of intravenous iron sucrose" (12) and "Sustainable Synthesis of Noroxymorphone via a Key Electrochemical N-Demethylation Step" (10).

Most cited papers
#PaperReleasedCitations
1 Physicochemical and toxicological characterization of a new generic iron sucrose preparation Thomas W. Meier, Patricia Schropp, Christian Pater et al. · Arzneimittelforschung 28 Nov 2011 21
2 Biodistribution and predictive hepatic gene expression of intravenous iron sucrose Peter R. Elford, Johanne Bouchard, Léonore Jaillet et al. · Journal of Pharmacological and Toxicological Methods 25 Apr 2013 12
3 Sustainable Synthesis of Noroxymorphone via a Key Electrochemical N-Demethylation Step Florian Sommer, Roman Gerber Aeschbacher, Urs Thurnheer et al. · ACS Sustainable Chemistry & Engineering Open access 29 Jun 2022 10
4 A new metabolite of Paricalcitol: stereoselective synthesis of (22Z)-isomer of 1α,25-dihydroxy-19-norvitamin D2 Ramakrishna Samala, Somesh Sharma, Manas K. Basu et al. · Tetrahedron Letters 14 Feb 2016 6
5 Alternative Synthesis of Cobimetinib Mikayel L. Movsisyan, Mariam H. Gharibyan, Nairi K. Gasparyan et al. · Pharmaceutical Chemistry Journal Apr 2024 2
All 7 most cited papers, with filters and sorting

Which research topics does AZAD Pharma (Switzerland) publish most on?

By volume in 2022-now: Chemical Synthesis and Analysis, Synthesis of β-Lactam Compounds, Chemical synthesis and alkaloids and Quinazolinone synthesis and applications.

  1. 1 Chemical Synthesis and Analysis Molecular Biology 1 works
  2. 2 Synthesis of β-Lactam Compounds Organic Chemistry 0 works
  3. 3 Chemical synthesis and alkaloids Organic Chemistry 0 works
  4. 4 Quinazolinone synthesis and applications Organic Chemistry 0 works
  5. 5 Asymmetric Synthesis and Catalysis Organic Chemistry 0 works
  6. 6 Chemistry and Chemical Engineering Environmental Chemistry 0 works
  7. 7 Chemical Synthesis and Reactions Organic Chemistry 0 works
  8. 8 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available11.5%not open88.5%

World: 40% of research is openly available.

with international co-authors11.5%domestic only88.5%

World: 18% is written across borders.

How has AZAD Pharma (Switzerland)'s research output changed?

20152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Schaffhausen

All research institutions in Schaffhausen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about AZAD Pharma (Switzerland). Posts are plain text and can be reported.